AVIEMORE, UNITED KINGDOM — (Marketwired) — 12/03/13 — Quarch Technology Ltd, leaders in test automation, have announced a new range of test modules for use with the latest generation of PCIe attached storage.The Quarch PCIe SFF Drive Module will allow fully automated hot-plug, lane failure and fault injection testing of the next generation of storage devices.The module transparently switches and sequences every PCIe power, data, and sideband signal of the SFF-8639 connector. This allows comp
REDWOOD CITY, CA — (Marketwired) — 12/03/13 — ASSIA, Inc., a leading solutions company for broadband service providers, announced that today the High Court of Justice in London ruled that two ASSIA patents on DSL management technologies are valid and that British Telecom infringes one of the patents.The court determined that BT uses ASSIA-s patented DSL management technology in BT-s Next Generation Access ("NGA") network. NGA is the fastest growing portion of BT-s broadband network
BOCA RATON, FL — (Marketwired) — 12/03/13 — (PINKSHEETS: DUBL), a global marketing company that provides consumers around the world with a variety of innovative , travel and entertainment opportunities, today announced that it has launched a co-branded Partner Program for companies, organizations and charities around the world to take advantage of DubLi-s ecommerce website.The DubLi Partner Program allows companies and organizations to co-brand DubLi-s ecommerce platform. The DubLi Partner
PISCATAWAY, NJ — (Marketwired) — 12/03/13 — Following its endorsement of ZigBee Light Link as the preferred common open standard for residential connected lighting applications, The Connected Lighting Alliance announced today the launch of a new initiative focused on the indoor professional lighting market. The Alliance will analyze market requirements for indoor professional lighting applications and identify standard development organizations to engage with. As an open association, the All
Protagen announced today that a collaboration agreement with Pfizer Inc. has been signed. Under the collaboration, Protagen will use its proprietary SeroTag® process to attempt to discover prediction or patient stratification markers for a novel drug being developed by Pfizer.
Protagen CEO Stefan Müllner comments, "The current agreement shows that the SeroTag® process of Protagen is relevant technology to explore novel biomarkers in support of clinical development in i
